Clinical trials
Volunteers clinical trials
Below are recruiting volunteers clinical trials, each written for real people, not researchers. We’re tracking 525 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07558668RecruitingPhase 1
Testing SYX-5219 for atopic dermatitis in healthy people and patients
This trial tests a new drug called SYX-5219 to see if it is safe and how the body handles it. Part 1 and 2 use healthy volunteers, while Part 3 tests it in people with moderate to severe atopic dermatitis (eczema). The goal is to understand if this drug might help treat eczema symptoms like itching and skin inflammation.
Arkansas City, ArkansasAges 18–65 - NCT07554222RecruitingPhase 1
Safety study of IBI3013 for vitiligo and hair loss
This is an early-stage safety study of a new drug called IBI3013. The trial tests how safe the drug is and how your body processes it. It enrolls healthy volunteers first, then people with vitiligo (loss of skin color) or severe alopecia areata (patchy hair loss).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05587036RecruitingPhase 2/Phase 3
Rifaximin study to see how gut bacteria affect mood
This trial tests whether a gut-targeting antibiotic called rifaximin changes the gut microbiome (gut bacteria) and affects emotion. It is looking for healthy men so any mood or gut changes can be more clearly linked to the study treatment.
LeuvenAges 18–50 - NCT07549919RecruitingPhase 1
Food Effects on a New Experimental Drug in Healthy Men
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
Los Alamitos, CaliforniaAges 18–55 - NCT07544875Recruiting
Brain Training Program for Adults in Hong Kong
This volunteer training program in Hong Kong teaches brain exercises and cognitive skills to adults age 50 and older. The program aims to help keep your mind sharp and may improve memory and thinking abilities.
Hong KongAges 50 years+ - NCT07539415RecruitingPhase 1
Safety and effectiveness study of new injection in healthy adults
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
SeoulAges 19–64 - NCT07542158Enrolling by invitationPhase 2
Ultra-Low Radiation PET Imaging Study for Brain Scanning
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
Englewood, New JerseyAges 18–120 - NCT07525947RecruitingPhase 1
Safety Study of JADE101 in Healthy Japanese and Chinese Adults
This is an early-stage safety study of an experimental medicine called JADE101. Researchers want to give a single dose to healthy volunteers of Japanese or Chinese heritage to see how the body handles it and watch for any side effects.
Glendale, CaliforniaAges 18–55 - NCT07526116RecruitingPhase 1
Safety study of REGN22044 in healthy adults
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Ghent, Oost-VlaanderenAges 18–65 - NCT07526519RecruitingPhase 1
Safety study of TL-003 for healthy adults and ulcerative colitis
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
Perth, Western AustraliaAges 18–55 - NCT07527923RecruitingPhase 1
Testing REGN20423 for healthy people and atopic dermatitis
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
Birmingham, AlabamaAges 18–65 - NCT07531316RecruitingPhase 1
Safety study of VVZ-2471 in healthy volunteers with high impulsivity
This Phase 1 study tests how safe and well-tolerated a new experimental drug called VVZ-2471 is in healthy adults. The drug targets brain pathways involved in impulse control, and researchers want to understand its effects on people who naturally tend to act without thinking.
Richmond, VirginiaAges 18–65 - NCT07521189Recruiting
How Diet Type Affects Protein Digestion in Young and Older Adults
This study compares how well the body digests protein from plant-based versus meat-based diets in young adults (18–23) and older adults (65–75). Researchers want to understand if age and diet type affect how efficiently your body uses protein from food.
BobignyAges 18–75 - NCT07522970RecruitingPhase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07516405RecruitingPhase 1
Psilocybin Safety Study in Older Adults
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
San Francisco, CaliforniaAges 65–85 - NCT07507838RecruitingEarly Phase 1
Safety study of VV913 capsules in healthy male volunteers
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
Hefei, AnhuiAges 18–45 - NCT07514780RecruitingPhase 1
Safety study of JW0061 in healthy adults
This is an early-stage safety test of a new drug called JW0061 in people without serious health conditions. Researchers will monitor how your body processes the drug and any side effects that occur.
Seoul, SeoulAges 19–55 - NCT07515638Recruiting
Immune System Study for Autoimmune Diseases
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
MontpellierAges 18 years+ - NCT07504003Recruiting
How exercise session length affects your body's resilience
This study looks at how the length of your exercise sessions affects your body's ability to adapt and get stronger over time. It's designed for people who are already active but not training more than 2 hours a week.
Saint-EtienneAges 18–45 - NCT06767410Recruiting
A program to support healthy aging in older adults
This study tests a multi-domain intervention (combining different healthy habits like physical, mental, and social activities) to see if it helps older adults age well. You may join if you are 65 or older and live on your own.
Adelfia, BariAges 65 years+ - NCT07497503RecruitingPhase 1
Study of B-3E07 and Forsteo in healthy women
This trial tests a new medicine called B-3E07 together with Forsteo (a bone-strengthening drug) in healthy women. It aims to see if the combination is safe and how the body processes it.
Bayswater, VictoriaAges 18–45 - NCT06703710RecruitingPhase 1
Safety study of a new drug in healthy volunteers
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
SeoulAges 19–50 - NCT07471932RecruitingPhase 1
Testing a new skin medicine in healthy adults
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
LeidenAges 18–45 - NCT07476586RecruitingPhase 1
Study of GenSci161 safety in healthy adults
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
Shanghai, Shanghai MunicipalityAges 18–45
Hear when a new Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for volunteers?
- Yes. Clin2 currently lists 525 recruiting volunteers studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a volunteers trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a volunteers trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.